HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model
2015-01-01 Ceriani, L; Ferrari, M; Zangarini, M; Licandro, Sa; Bello, E; Frapolli, R; Falcetta, F; D'Incalci, M; Libener, R; Grosso, F; Aviles, P; Zucchetti, M
Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in NER deficient and proficient cells, unravelled by a novel mathematical simulation approach
2008-01-01 Tavecchio, M; Natoli, C; Ubezio, P; D'Incalci, M; Erba, E
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
2009-01-01 Sala, F; Zucchetti, M; Bagnati, R; D'Incalci, M; Pace, S; Capocasa, F; Marangon, E
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph plus acute leukemias
2009-01-01 Marangon, E; Citterio, M; Sala, F; Barisone, E; Lippi, Aa; Rizzari, C; Biondi, A; D'Incalci, M; Zucchetti, M
Effect of Ecteinascidin-743 (ET-743) on the interaction between transcription factors and DNA
1998-01-01 Mantonvani, R; La Valle, E; Bonfanti, M; Sousa-Faro, Jmf; Faircloth, G; D'Incalci, M
3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines
1996-01-01 Damia, G; Imperatori, L; Citti, L; Mariani, L; D'Incalci, M
Trabectedin in ovarian cancer: could we expect more?
2011-01-01 Sessa, C; D'Incalci, M
Analysis of Gene Expression in Early-Stage Ovarian Cancer
2008-01-01 Marchini, S; Mariani, P; Chiorino, G; Marrazzo, E; Bonomi, R; Fruscio, R; Clivio, L; Garbi, A; Torri, V; Cinquini, M; Dell'Anna, T; Apolone, G; Broggini, M; D'Incalci, M
Role of P21 in sensitivity to DACH-platinum compounds, oxaliplatin and ProLindac, in human cancer cells
2008-01-01 Serova, M; Bieche, I; Broggini, M; Erba, E; Ghoul, A; D'Incalci, M; Cvitkovic, E; Nowotniks, D; Faivre, S; Raymond, E
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma
2013-01-01 Gallerani, E; Zucchetti, M; Brunelli, D; Marangon, E; Noberasco, C; Hess, D; Delmonte, A; Martinelli, G; Bohm, S; Driessen, C; De Braud, F; Marsoni, S; Cereda, R; Sala, F; D'Incalci, M; Sessa, C
Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation
2000-01-01 Conforti, G.; Nardo, T.; D'Incalci, M; Stefanini, M
The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells
1999-01-01 Erba, E; Ronzoni, S; Bassano, L; Giavazzi, R; D'Incalci, M
Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer
2016-01-01 Sitia, L; Ferrari, R; Violatto, Mb; Talamini, L; Dragoni, L; Colombo, C; Colombo, L; Lupi, M; Ubezio, P; D'Incalci, M; Morbidelli, M; Salmona, M; Moscatelli, D; Bigini, P
Small interfering RNA delivery through positively charged polymer nanoparticles
2016-01-01 Dragoni, L; Ferrari, R; Lupi, M; Cesana, A; Falcetta, F; Ubezio, P; D'Incalci, M; Morbidelli, M; Moscatelli, D
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin
2013-01-01 D'Angelo, D; Borbone, E; Palmieri, D; Uboldi, S; Esposito, F; Frapolli, R; Pacelli, R; D'Incalci, M; Fusco, A
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients
2006-01-01 Fruscio, R; Lissoni, Aa; Frapolli, R; Corso, S; Mangioni, C; D'Incalci, M; Zucchetti, M
TRABECTEDIN: A SOMETHING NEW IN ONCOLOGY
2011-01-01 Erba, E; Uboldi, S; Romano, M; Bernasconi, S; Panini, N; Marchini, S; Fuso, Ni; Frapolli, R; D'Incalci, M
alpha-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity
1999-01-01 Marchini, S; Ciro, M; Gallinari, F; Geroni, C; Cozzi, P; D'Incalci, M; Broggini, M
Molecular characterisation of a panel of human ovarian carcinoma xenografts
1998-01-01 Codegoni, Am; Nicoletti, Mi; Buraggi, G; Valoti, G; Giavazzi, R; D'Incalci, M; Landoni, F; Maneo, A; Broggini, M
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells
2016-01-01 Mezzapelle, R; Rrapaj, E; Gatti, E; Ceriotti, C; De Marchis, F; Preti, A; Spinelli, Ae; Perani, L; Venturini, M; Valtorta, S; Moresco, Rm; Pecciarini, L; Doglioni, C; Frenquelli, M; Crippa, L; Recordati, C; Scanziani, E; de Vries, H; Berns, A; Frapolli, R; Boldorini, R; D'Incalci, M; Bianchi, Me; Crippa, Mp
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model | 1-gen-2015 | Ceriani, L; Ferrari, M; Zangarini, M; Licandro, Sa; Bello, E; Frapolli, R; Falcetta, F; D'Incalci, M; Libener, R; Grosso, F; Aviles, P; Zucchetti, M | |
| Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in NER deficient and proficient cells, unravelled by a novel mathematical simulation approach | 1-gen-2008 | Tavecchio, M; Natoli, C; Ubezio, P; D'Incalci, M; Erba, E | |
| Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study | 1-gen-2009 | Sala, F; Zucchetti, M; Bagnati, R; D'Incalci, M; Pace, S; Capocasa, F; Marangon, E | |
| Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph plus acute leukemias | 1-gen-2009 | Marangon, E; Citterio, M; Sala, F; Barisone, E; Lippi, Aa; Rizzari, C; Biondi, A; D'Incalci, M; Zucchetti, M | |
| Effect of Ecteinascidin-743 (ET-743) on the interaction between transcription factors and DNA | 1-gen-1998 | Mantonvani, R; La Valle, E; Bonfanti, M; Sousa-Faro, Jmf; Faircloth, G; D'Incalci, M | |
| 3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines | 1-gen-1996 | Damia, G; Imperatori, L; Citti, L; Mariani, L; D'Incalci, M | |
| Trabectedin in ovarian cancer: could we expect more? | 1-gen-2011 | Sessa, C; D'Incalci, M | |
| Analysis of Gene Expression in Early-Stage Ovarian Cancer | 1-gen-2008 | Marchini, S; Mariani, P; Chiorino, G; Marrazzo, E; Bonomi, R; Fruscio, R; Clivio, L; Garbi, A; Torri, V; Cinquini, M; Dell'Anna, T; Apolone, G; Broggini, M; D'Incalci, M | |
| Role of P21 in sensitivity to DACH-platinum compounds, oxaliplatin and ProLindac, in human cancer cells | 1-gen-2008 | Serova, M; Bieche, I; Broggini, M; Erba, E; Ghoul, A; D'Incalci, M; Cvitkovic, E; Nowotniks, D; Faivre, S; Raymond, E | |
| A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma | 1-gen-2013 | Gallerani, E; Zucchetti, M; Brunelli, D; Marangon, E; Noberasco, C; Hess, D; Delmonte, A; Martinelli, G; Bohm, S; Driessen, C; De Braud, F; Marsoni, S; Cereda, R; Sala, F; D'Incalci, M; Sessa, C | |
| Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation | 1-gen-2000 | Conforti, G.; Nardo, T.; D'Incalci, M; Stefanini, M | |
| The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells | 1-gen-1999 | Erba, E; Ronzoni, S; Bassano, L; Giavazzi, R; D'Incalci, M | |
| Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer | 1-gen-2016 | Sitia, L; Ferrari, R; Violatto, Mb; Talamini, L; Dragoni, L; Colombo, C; Colombo, L; Lupi, M; Ubezio, P; D'Incalci, M; Morbidelli, M; Salmona, M; Moscatelli, D; Bigini, P | |
| Small interfering RNA delivery through positively charged polymer nanoparticles | 1-gen-2016 | Dragoni, L; Ferrari, R; Lupi, M; Cesana, A; Falcetta, F; Ubezio, P; D'Incalci, M; Morbidelli, M; Moscatelli, D | |
| The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin | 1-gen-2013 | D'Angelo, D; Borbone, E; Palmieri, D; Uboldi, S; Esposito, F; Frapolli, R; Pacelli, R; D'Incalci, M; Fusco, A | |
| Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients | 1-gen-2006 | Fruscio, R; Lissoni, Aa; Frapolli, R; Corso, S; Mangioni, C; D'Incalci, M; Zucchetti, M | |
| TRABECTEDIN: A SOMETHING NEW IN ONCOLOGY | 1-gen-2011 | Erba, E; Uboldi, S; Romano, M; Bernasconi, S; Panini, N; Marchini, S; Fuso, Ni; Frapolli, R; D'Incalci, M | |
| alpha-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity | 1-gen-1999 | Marchini, S; Ciro, M; Gallinari, F; Geroni, C; Cozzi, P; D'Incalci, M; Broggini, M | |
| Molecular characterisation of a panel of human ovarian carcinoma xenografts | 1-gen-1998 | Codegoni, Am; Nicoletti, Mi; Buraggi, G; Valoti, G; Giavazzi, R; D'Incalci, M; Landoni, F; Maneo, A; Broggini, M | |
| Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells | 1-gen-2016 | Mezzapelle, R; Rrapaj, E; Gatti, E; Ceriotti, C; De Marchis, F; Preti, A; Spinelli, Ae; Perani, L; Venturini, M; Valtorta, S; Moresco, Rm; Pecciarini, L; Doglioni, C; Frenquelli, M; Crippa, L; Recordati, C; Scanziani, E; de Vries, H; Berns, A; Frapolli, R; Boldorini, R; D'Incalci, M; Bianchi, Me; Crippa, Mp |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891